Seeking Alpha

Keryx Biopharmaceuticals (KERX) and AEterna Zentaris (AEZS) move lower in premarket trading...

Keryx Biopharmaceuticals (KERX) and AEterna Zentaris (AEZS) move lower in premarket trading after the credibility of Jeremy Richards is openly questioned by Adam Feuerstein. Richards claimed that FDA approval on colon cancer drug perifosine was "practically a done deal" in a SA piece. KERX -7.7%, AEZS -12.2%.
Comments (1)
  • KJP712
    , contributor
    Comments (454) | Send Message
     
    Looks like someone big had to get out of their short position.Keep the faith and buy more at these prices.Actually the article yesterday was right on target.
    6 Mar 2012, 10:58 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs